SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-006004
Filing Date
2019-04-26
Accepted
2019-04-26 16:34:30
Documents
4
Period of Report
2019-04-26
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 331664
2 image_001.jpg GRAPHIC 3447
3 image_002.jpg GRAPHIC 102943
4 image_003.jpg GRAPHIC 97481
  Complete submission text file 0001493152-19-006004.txt   613742
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38738 | Film No.: 19772201
SIC: 2834 Pharmaceutical Preparations